Boston’s Massachusetts General Hospital has won more than $10 million contract from US department of defense to conduct research for a US military genetic engineering program.
“Massachusetts General Hospital of Boston, Massachusetts was awarded a cooperative agreement with a ceiling value of $11 million for research and development supporting the Safe Genes program,” the US department of defence announced Friday.
The Safe Genes program delivers biological capabilities for advanced genome editing applications, DARPA states. The work will be overseen by the Defense Advanced Research Projects Agency based in Arlington, Virginia.
The project has an expected completion date of April 2021, the Defense Department said.